Document Classification

Section Type: RESULTS

Text: INT lowered glycated hemoglobin (by a median of 2 % vs. a median of 0. 7 % by standard treatment ; P < 0. 0001) ; increased BMI (4 vs. 1 % ; P < 0. 001), total HDL (9 vs. 4 % ; P < 0. 05), HDL2 (14 vs. 0 % ; P = 0. 009), LDL2 (36 vs. 1 % ; P < 0. 0001), and plasma adiponectin (130 vs. 80 % ; P < 0. 01) ; and reduced triglycerides (-13 vs. -4 % ; P = 0. 02) and small, dense LDL4 (-39 vs. -13 % ; P < 0. 001), but had no effect on levels of plasma apolipoproteins B-100 and B-48, C-reactive protein, interleukin-6, lipoprotein-associated phospholipase A2, myeloperoxidase, fibrinogen, and plasminogen activator inhibitor 1.